...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.

Thanks for posting 10-41.

So the trials have not started yet if I read the article properly.

I feel that the photos featuring the research scientist Christopher Sarsons were an excellent choice because they give an image of RVX as young, bright scientists. It lends an image of legitimacy and youthful scientific energy. They should do more of this.

Good to see the communicatios effort. The BETi, epigenetic and apabetalone messages are complex messages. RVX should have professional communications experts developing the executions. Of course this is a pipe dream given RVX's failure(s) to finance effectively.

GLTA

Toinv

Share
New Message
Please login to post a reply